Chips, anyone?

Protect patients, health workers and facilities: WHO to all parties in Afghanistan

The World Health Organization was committed to staying in Afghanistan and delivering critical health services, it said

A heavy burden

In 2016, over 95 per cent of TB deaths happened in low- and middle-income countries

New sensor may help early detection of prostate cancer

Researchers will measure levels of spermine and spermidine in blood and urine for a more accurate test

Treated, but partly

The Indian government has heavily slashed the prices of coronary stents. Will patients with heart conditions benefit from it?

Like COVID, TB is a pandemic and must be treated as an emergency

If we do not behave like TB is a global health emergency, we will continue to experience unacceptable suffering from a disease that has killed …

Now, TB test recommended for COVID-19 patients in case of persisting cough

Experts hail decision as opportunity to increase detection of both COVID-19 and TB

COVID-19: India to miss TB case notification target for 2021

India contributed the biggest drop in global case notifications last year

India, Indonesia and the Philippines account for over 60% drop in tuberculosis reporting in 2020 and 2021

WHO report finds TB still world’s second leading cause of death from a single infectious agent

Many poor patients forego operation

They don't have family attendants to care for them after surgery

World’s first ‘Darwinian’ cancer drug plan could be a game changer

The programme based on artificial intelligence that will help forecast cancers and treat them better could be of immense benefit to patients …

COVID-19 cost: Dialysis takes a backseat

Pain for patients with kidney ailments as volume of novel coronavirus cases increases

Diet, lifestyle, environmental changes linked to massive cancer cases spike in under-50 adults globally

79% surge in cancer cases from 1990 to 2019, finds report

Anti-cancer CAR-T therapy reengineers T cells to kill tumors — and researchers are expanding the limited types of cancer it can target

Researchers have been developing a novel type of therapy that directly gives patients a new set of T cells engineered to attack tumors

World Tuberculosis Day: At 316 per lakh, India’s TB prevalence higher than WHO estimations

Gujarat has the lowest burden of all forms of TB, while Kerala is the lowest in pulmonary TB, according to the National TB Prevalence Survey 2019-2021

Sun Pharma, Novartis settle lawsuit over Glivec

Sun Pharma allowed to launch generic version of anti-leukamia drug next year

EWS quota: Delhi government to crack whip on private hospitals

All private hospitals should have beds reserved for poor, says an activist

Win one, lose many

India needs to have a hard look at the sources of all its varied traditional knowledge and how to protect them

Gender inequities worsen impact of cancer in women, finds Lancet Commission

Discrimination affects their rights and opportunities to avoid risk factors, ability to get timely diagnosis & quality care

‘Making TB a notifiable disease will benefit patients’

Tuberculosis kills around 1,000 people each day in India and more than two million people are affected by the bacterial disease. This makes India …

Asymptomatic family contacts form bulk of COVID-19 cases in India: ICMR study

Nearly 40,000 individuals out of 1 mln tested positive for SARS-CoV-2 between Jan 22 and April 30, 2020. About 25.3% of them were asymptomatic …

Evergreen Novartis

The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy

Lung infections to panic attacks: Those who ‘beat’ COVID-19, but did not recover

Amid studies hinting at long-term impacts of COVID-19 infection, the world, including India, has started monitoring people who recovered from the …

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

Novartis loses patent appeal in landmark suit

Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …